|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, November 18, 2016 ) The global oncology biosimilars market will witness substantial growth over the forecast period and is expected to grow at very impressive CAGR during the forecast period. The increasing need for cost-effective treatment methodologies will aid in the stable growth of this market during the forecast period. The high cost of branded biologic oncological drugs will force patients to shift toward biosimilars as they are highly cost-effective. Since biosimilars cost 10%-30% lesser than their parent counterparts, there is the presence of unmet medical needs for such products. This allows domestic manufacturers to market generic versions of the biologic compounds at a lower price, which in turn results in market growth.
This report provides comprehensive analysis of
Key market segments and sub-segments
Evolving market trends and dynamics
Changing supply and demand scenarios
Quantifying market opportunities through market sizing and market forecasting
Tracking current trends/opportunities/challenges
Competitive insights
Opportunity mapping in terms of technological breakthroughs
For More Information View Complete Report at http://www.reportsweb.com/global-oncology-biosimilars-market-research-report-forecast-2016-2021
Global Oncology Biosimilars Market: Regional Segment Analysis
North America
Europe
China
Japan
Southeast Asia
India
The Major players reported in the market include:
Biocon
Amgen
Celltrion
Hospira
Biogen
Mylan
Pfizer
Dr. Reddy's Laboratories
Roche
GlaxoSmithKline (GSK)
Merck
Sanofi and Sandoz.
Collect Sample Copy for More Information at http://www.reportsweb.com/inquiry&RW0001460028/sample
Reasons for Buying this Report
This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth
It provides a six-year forecast assessed on the basis of how the market is predicted to grow
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
It provides distinctive graphics and exemplified SWOT analysis of major market segments
Major Points from Table of Contents
Chapter 1 Oncology Biosimilars Market Overview
Chapter 2 Global Economic Impact on Oncology Biosimilars Industry
Chapter 3 Global Oncology Biosimilars Market Competition by Manufacturers
Chapter 4 Global Oncology Biosimilars Production, Revenue (Value) by Region (2011-2016)
Chapter 5 Global Oncology Biosimilars Supply (Production), Consumption, Export, Import by Regions (2011-2016)
Chapter 6 Global Oncology Biosimilars Production, Revenue (Value), Price Trend by Type
Chapter 7 Global Oncology Biosimilars Market Analysis by Application
Chapter 8 Global Oncology Biosimilars Manufacturers Profiles/Analysis
Chapter 9 Oncology Biosimilars Manufacturing Cost Analysis
Chapter 10 Industrial Chain, Sourcing Strategy and Downstream Buyers
For Discount Inquire at http://www.reportsweb.com/inquiry&RW0001460028/discount
Chapter 11 Analysis of Investment Strategy
Chapter 12 Marketing Strategy Analysis, Distributors/Traders
Chapter 13 Market Effect Factors Alysis
Chapter 14 Global Oncology Biosimilars Market Forecast (2016-2021)
Chapter 15 Research Findings and Conclusion
Chapter 16 Appendix
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
